Japan's National Center for Global Health and Medicine (NCGM) is planning a clinical trial of Teijin's alvesco (ciclesonide), an inhaled corticosteroid used for asthma, for the treatment of pre-symptomatic patients infected with the new coronavirus.
Kituo cha Kitaifa cha Afya na Tiba ya Jumuiya huko Japani (NCGM) inapanga jaribio la kliniki la Teijin&apos;s Alvesco (ciclesonide), corticosteroid ya kuvuta puani kwa ajili ya pumu, kwa matibabu ya wagonjwa wenye pumu walioambukizwa na virusi vipya vya korona.